SCHEMBL28063709

SCHEMBL28063709

C1CC(CNC2CNC2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.37
ADH1C P00326 1/20 0.37
ADH1A P07327 1/20 0.37
ADH4 P08319 1/20 0.37
ADH7 P40394 1/20 0.37
KCNH2 Q12809 1/20 0.35
EPHX1 P07099 2/20 0.35
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
MAN1B1 Q9UKM7 1/20 0.33
GLB1 P16278 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28254730 0.98 ADH1B (0.35) ADH1BADH1CADH1AADH4ADH7
SCHEMBL28063707 0.90
Hydrochloric Acid SCHEMBL28254756 0.88 KCNH2 (0.37) KCNH2MAN1B1KDM1AMAOB
SCHEMBL4635186 0.85 KCNH2 (0.55) ADH1BADH1CADH1AADH4ADH7
SCHEMBL31014239 0.83 KCNH2 (0.44) ADH1BADH1CADH1AADH4ADH7
SCHEMBL31014227 0.83 KCNH2 (0.44) ADH1BADH1CADH1AADH4ADH7
SCHEMBL9012380 0.79 ADH1B (0.42) ADH1BADH1CADH1AADH4ADH7
SCHEMBL1679210 0.79
SCHEMBL27804953 0.79 GNAI3 (0.41) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3812253 0.79 KCNH2 (0.53) ADH1BADH1CADH1AADH4ADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105492433-B 6- (5-hydroxy-1H-pyrazol-1-yl) nicotinamide derivatives and their use as PHD inhibitors 武田药品工业株式会社 2018-11-23 CN disclosed
CN-105492433-A 6- (5-hydroxy-1H-pyrazol-1-yl) nicotinamide derivatives and their use as PHD inhibitors TAKEDA PHARMACEUTICALS CO 2016-04-13 CN disclosed